Ildong Pharmaceutical

Ildong Pharmaceutical Co., a South Korean drugmaker, considers seeking approval for a COVID-19 anti-viral pill from the country as Japan postponed g...

A string of South Korean pharmaceutical and biotech companies are waving the white flag when it comes to developing COVID-19 treatments. As the...

South Korea’s biopharmaceutical companies are close to commercializing a COVID-19 vaccine and treatment pill as they are on the brink of compl...

Biotechnology startups in Europe, backed by South Korea's SK Inc., are speeding up their development of next-generation drug candidates by joining h...

The US Food and Drug Administration has begun reviewing a medicine developed by South Korea’s Hanmi Pharmaceutical Co. for marketing authoriza...

Overseas technology transfers from South Korean biotechs and pharmaceutical manufacturers this year have exceeded 11 trillion won ($9.3 billion), al...

Voronoi Inc., a South Korean biotechnology startup, has clinched a $324 million deal to grant Brickell Biotech, a US clinical-stage pharmaceutical f...

South Korea-based Daewoong Pharmaceutical Co. is hoping to achieve 5 trillion won ($4.4 billion) in sales by 2027, meaning that the company aims to ...